Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

被引：0
|
作者：
Nakamura, Minoru
Kondo, Hisayoshi
Mori, Tsuyoshi
Komori, Atsumasa
Matsuyama, Mutsumi
Ito, Masahiro
Daikoku, Manabu
Yatsuhashi, Hiroshi
Takezaki, Eiichi
Masaki, Naohiko
Sugi, Kazuhiro
Adachi, Hiroshi
Sakai, Norihiro
Watanabe, Yukio
Saoshiro, Takeo
Honda, Koichi
Harada, Hideharu
Hayashi, Shigeki
Sando, Takehiro
Masumoto, Akihide
Shimada, Masaaki
Komatsu, Tatsuji
Shums, Zakera
Norman, Gary L.
Ishibashi, Hiromi
机构：
[1] Natl NHO Nagasaki Med Ctr, Clin Res Ctr, Omura, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hepatol, Omura, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Nagasaki 852, Japan
[4] NHO Study Grp Liver Dis Japan, Omura, Japan
[5] INOVA Diagnost, San Diego, CA USA
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1180
引用
收藏
页码：629A / 629A
页数：1
相关论文
共 50 条
  • [1] Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
    Nakamura, Minoru
    Kondo, Hisayoshi
    Mori, Tsuyoshi
    Komori, Atsumasa
    Matsuyama, Mutstuni
    Ito, Masahiro
    Takii, Yasushi
    Koyabu, Makiko
    Yokoyama, Terufumi
    Migita, Kiyoshi
    Daikoku, Manabu
    Abiru, Seigo
    Yatsuhashi, Hiroshi
    Takezaki, Eiichi
    Masaki, Naohiko
    Sugi, Kazuhiro
    Honda, Koichi
    Adachi, Hiroshi
    Nishi, Hidehiro
    Watanabe, Yukio
    Nakamura, Yoko
    Shimada, Masaaki
    Komatsu, Tatsuji
    Saito, Akira
    Saoshiro, Takeo
    Harada, Hideharu
    Sodeyama, Takeshi
    Hayashi, Shigeki
    Masumoto, Akihide
    Sando, Takehiro
    Yamamoto, Tetsuo
    Sakai, Hironori
    Kobayashi, Masakazu
    Muro, Toyokichi
    Koga, Michiaki
    Shums, Zakera
    Norman, Gary L.
    Ishibashi, Hiromi
    HEPATOLOGY, 2007, 45 (01) : 118 - 127
  • [2] The prognostic value of anti-gp210 and anti-centromere antibodies in patients with primary biliary cholangitis: Enhancing the prognostic utility on the GLOBE scoring system
    Ding, Dawei
    Jia, Gui
    Cui, Lina
    Liu, Yansheng
    Wang, Xiufang
    Sun, Ruiqing
    Deng, Juan
    Guo, Guanya
    Shang, Yulong
    Han, Ying
    DIGESTIVE AND LIVER DISEASE, 2025, 57 (04) : 861 - 868
  • [3] Kinetics of anti-gp210 antibodies in primary biliary cirrhosis patients with ursodesoxycholic acid therapy
    Boissan, M
    Ballot, E
    Johanet, C
    AUTOANTIGENS AND AUTOANTIBODIES: DIAGNOSTIC TOOLS AND CLUES TO UNDERSTANDING AUTOIMMUNITY, 2000, 1 : 507 - 508
  • [4] Anti-gp210 and anti-centromere antibodies for the prediction of PBC patients with an incomplete biochemical response to UDCA and bezafibrate
    Honda, Akira
    Ikegami, Tadashi
    Matsuzaki, Yasushi
    HEPATOLOGY RESEARCH, 2015, 45 (08) : 827 - 828
  • [5] Anti-gp210 and anti-Sp100 antibodies in primary biliary cholangitis
    Ben Lamine, Zeineb
    Ben Jazia, Ilhem
    Ben Ahmed, Mariem
    Ben Slama, Ayda
    Baccouche, Azza
    Slama, Foued
    Jemaa, Ali
    Ghedira, Ibtissem
    Mankai, Amani
    ARAB JOURNAL OF GASTROENTEROLOGY, 2021, 22 (04) : 316 - 320
  • [6] Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis
    Liberal, Rodrigo
    Grant, Charlotte R.
    Sakkas, Lazaros
    Bizzaro, Nicola
    Bogdanos, Dimitrios P.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2013, 37 (06) : 572 - 585
  • [7] Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis
    Bogdanos, Dimitrios P.
    Liaskos, Christos
    Pares, Albert
    Norman, Gary
    Rigopoulou, Eirini I.
    Caballeria, Llorenc
    Dalekos, George N.
    Rodes, Juan
    Vergani, Diego
    HEPATOLOGY, 2007, 45 (06) : 1583 - 1583
  • [8] Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis
    Nakamura, Minoru
    Komori, Atsumasa
    Ito, Masahiro
    Kondo, Hisayoshi
    Aiba, Yoshihiro
    Migita, Kiyoshi
    Nagaoka, Shinya
    Ohata, Kazuyuki
    Yano, Koji
    Abiru, Seigo
    Daikoku, Manabu
    Yatsuhashi, Hiroshi
    Shimoda, Shinji
    Ishibashi, Hiromi
    HEPATOLOGY RESEARCH, 2007, 37 : S412 - S419
  • [9] Detection of anti-gp210 antibodies in primary biliary cirrhosis by enzyme-linked immunosorbent assay with a synthesized polypeptide
    Shibata, M
    Ouya, K
    Hachiya, T
    Tamai, K
    Miyachi, K
    Horigome, T
    Onozuka, Y
    Ueno, Y
    Morizane, T
    Mitamura, K
    PROGRESS IN HEPATOLOGY, VOL 5: LIVER AND IMMUNOLOGY, 1999, 1188 : 125 - 133
  • [10] ANTI-GP210 ANTIBODY IS A SEROLOGICAL MARKER FOR THE PROGRESSION TO END-STAGE ENLARGED LIVER WITH MICRONODULAR CIRRHOSIS IN PRIMARY BILIARY CIRRHOSIS
    Nakamura, M.
    Mori, A.
    Tanaka, T.
    Yamashiki, N.
    Shirabe, K.
    Maehara, Y.
    Kokudo, N.
    Uemoto, S.
    Aishima, S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S788 - S788
12345